EcoDrugPlus

Histone Deacetylase 7-Like

Ensembl ID : ENSLBEG00000020714
Gene Symbol: LOC109993810
2 Cross references
195 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSLBEG00000001613
Gene Symbol: HDAC8
3 Cross references
204 Possible Orthologues:

Histone Deacetylase 8-Like

Ensembl ID : ENSLBEG00000009984
Gene Symbol: LOC109976961
3 Cross references
204 Possible Orthologues:

Histone-Lysine N-Methyltransferase Ezh2-Like

Ensembl ID : ENSLBEG00000015099
Gene Symbol: LOC109993135
3 Cross references
229 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSLBEG00000010562
Gene Symbol: HCN4
3 Cross references
221 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSLBEG00000013727
Gene Symbol: HCN4
4 Cross references
212 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSLBEG00000025077
Gene Symbol: HCRTR2
3 Cross references
203 Possible Orthologues:

Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1-Like

Ensembl ID : ENSLBEG00000026861
Gene Symbol: LOC109999085
3 Cross references
211 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa-B Kinase Subunit Beta-Like

Ensembl ID : ENSLBEG00000024869
Gene Symbol: LOC109991608
3 Cross references
199 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSLBEG00000008119
Gene Symbol: IMPDH2
4 Cross references
200 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1b

Ensembl ID : ENSLBEG00000013130
Gene Symbol: LOC109997904
4 Cross references
257 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1b-Like

Ensembl ID : ENSLBEG00000012878
Gene Symbol: LOC109998163
4 Cross references
258 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).